SCHEMBL25517601

SCHEMBL25517601

Clc1ccc(-c2ccc(C34CC5C[C@H](C3)C[C@@H](C5)C4)c3ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 6/20 0.37
NR0B2 Q15466 2/20 0.37
PTPRCAP Q14761 2/20 0.36
LMNA P02545 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HTT P42858 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RARB P10826 1/20 0.34
RARG P13631 1/20 0.34
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25502766 1.00 PTPN11 (0.37) PTPN11NR0B2PTPRCAPLMNASMN1; SMN2
SCHEMBL19089827 0.86 LMNA (0.46) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL26157528 0.80 PSEN1 (0.33) KMT2AALDH1A1KDM4EHPGDCYP1A2
SCHEMBL25573258 0.77 BCL2 (0.32) MEN1KMT2ACYP1A2P2RX7
SCHEMBL25502815 0.76 MEN1 (0.44) PTPN11NR0B2SMN1; SMN2HTTMEN1
SCHEMBL25502777 0.76 MEN1 (0.44) PTPN11NR0B2SMN1; SMN2HTTMEN1
SCHEMBL12295925 0.74 CYP1A2 (0.57) LMNAKMT2AKDM4ECYP1A2GAA
SCHEMBL25125225 0.74 PTPN11 (0.34) PTPN11NR0B2PTPRCAPLMNASMN1; SMN2
SCHEMBL13004762 0.72 MEN1 (0.47) SMN1; SMN2HTTMEN1KMT2ARARB
SCHEMBL13004841 0.72 ALDH1A1 (0.35) LMNASMN1; SMN2HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11665958-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11665958-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof OR51E2, NFE2L2, ETV6 PTPN11 1988/4885NR0B2 2006/4885PTPRCAP 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.